Density and wrinkle changes appear at 8 to 12 weeks
The body tightly regulates B12 absorption through intrinsic factor, a protein produced in the stomach that binds to B12 and facilitates its uptake in the terminal ileum
For patients with pernicious anemia, severe malabsorption, or acute neurological symptoms, injections remain the appropriate clinical choice
Peptide therapy is generally not appropriate for patients who are pregnant, breastfeeding, have active hormone-sensitive cancers, or uncontrolled autoimmune conditions
Shows distinct binding dynamics versus native amylin and salmon calcitonin, with cryoEM data indicating unique conformational effects on CTR/RAMP complexes that may underlie its robust and durable anorectic activity
Neuroprotective Research An emerging body of laboratory research has begun to examine neuroprotective mechanisms associated with this copper-binding tripeptide in cell-based research models